Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyan Ye

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Annals of Translational Medicine|January 6, 2022
Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trialDanni Yao, Shuyan Ye, Ziyang He, et al.
Archives of Dermatological Research|August 20, 2024
Distinct adaptive immune receptor feature of adipose-derived mesenchymal stem cells (AD-MSCs) treatment of psoriasisLipeng Tang, Danni Yao, Ziyang He, et al.
Journal of Translational Medicine|March 26, 2026
Disentangling environmental and disease-specific signatures in the gut microbiome of psoriasis: discovery of Fimenecus sp. as a novel biomarker and characterization of the gut viromeJingwen Deng, Qinwei Qiu, Shuyan Ye, et al.
Frontiers in Pharmacology|February 7, 2022
The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine SyndromesYue Lu, Yao Qi, Li Li, et al.
Journal of Dermatological Science|August 5, 2023
Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasisJingwen Deng, Emmerik Leijten, Yongzhan Zhu, et al.
Frontiers in Immunology|September 26, 2022
Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasisQinwei Qiu, Jingwen Deng, Hao Deng, et al.
Clinical Rheumatology|September 17, 2024
Systematic analysis of serum peptidase inhibitor 3 in psoriasis diagnosis and treatmentMeng Xu, Hao Deng, Xiaomei Zhang, et al.
Drug Design, Development and Therapy|June 19, 2024
The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology AnalysisYue Lu, Simin Pan, Wenzhen Li, et al.
Frontiers in Pharmacology|February 14, 2022
Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription and Caspase-1-Regulated IL-1β SecretionLipeng Tang, Tong Li, Bowen Zhang, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
Elevated SNHG15 empowers keratinocytes hyperproliferation through activation of STAT3/Cyclin D1 axis in psoriasisLipeng Tang, Guanzhuo Li, Jiameng Chang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Annals of Translational Medicine|January 6, 2022
Adipose-derived mesenchymal stem cells (AD-MSCs) in the treatment for psoriasis: results of a single-arm pilot trialDanni Yao, Shuyan Ye, Ziyang He, et al.
Archives of Dermatological Research|August 20, 2024
Distinct adaptive immune receptor feature of adipose-derived mesenchymal stem cells (AD-MSCs) treatment of psoriasisLipeng Tang, Danni Yao, Ziyang He, et al.
Journal of Translational Medicine|March 26, 2026
Disentangling environmental and disease-specific signatures in the gut microbiome of psoriasis: discovery of Fimenecus sp. as a novel biomarker and characterization of the gut viromeJingwen Deng, Qinwei Qiu, Shuyan Ye, et al.
Frontiers in Pharmacology|February 7, 2022
The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine SyndromesYue Lu, Yao Qi, Li Li, et al.
Journal of Dermatological Science|August 5, 2023
Multi-omics approach identifies PI3 as a biomarker for disease severity and hyper-keratinization in psoriasisJingwen Deng, Emmerik Leijten, Yongzhan Zhu, et al.
Frontiers in Immunology|September 26, 2022
Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasisQinwei Qiu, Jingwen Deng, Hao Deng, et al.
Clinical Rheumatology|September 17, 2024
Systematic analysis of serum peptidase inhibitor 3 in psoriasis diagnosis and treatmentMeng Xu, Hao Deng, Xiaomei Zhang, et al.
Drug Design, Development and Therapy|June 19, 2024
The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology AnalysisYue Lu, Simin Pan, Wenzhen Li, et al.
Frontiers in Pharmacology|February 14, 2022
Punicalagin Alleviates Psoriasis by Inhibiting NF-κB-Mediated IL-1β Transcription and Caspase-1-Regulated IL-1β SecretionLipeng Tang, Tong Li, Bowen Zhang, et al.
Acta Pharmaceutica Sinica. B|January 1, 2026
Elevated SNHG15 empowers keratinocytes hyperproliferation through activation of STAT3/Cyclin D1 axis in psoriasisLipeng Tang, Guanzhuo Li, Jiameng Chang, et al.
Pageof 2